Coloplast appoints former J&J executive Gavin Wood as CEO
Denmark-based Coloplast has appointed Gavin Wood, a former senior executive at Johnson & Johnson, as its new President and Chief Executive Officer effective May 1, 2026. This appointment ends a ten month leadership search following the departure of Kristian Villumsen in May 2025. Wood joins the Danish medical device specialist from his recent role as Company Group Chairman of Johnson…
Novo Nordisk trims 11% of workforce to refocus on diabetes and obesity core
Danish multinational pharmaceutical company Novo Nordisk’s September restructuring marks its largest organisational reset in decades. The Denmark-based group is in the process of eliminating around 9,000 of 78,400 positions (c. 5,000 in Denmark) as it seeks to simplify decision-making, free up capital and defend leadership in the increasingly crowded GLP-1 diabetes-and-obesity arena. With headcount having risen 73 % since 2020, new…